isoxsuprine has been researched along with Alzheimer Disease in 2 studies
Isoxsuprine: A beta-adrenergic agonist that causes direct relaxation of uterine and vascular smooth muscle. Its vasodilating actions are greater on the arteries supplying skeletal muscle than on those supplying skin. It is used in the treatment of peripheral vascular disease and in premature labor.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
2 other studies available for isoxsuprine and Alzheimer Disease
Article | Year |
---|---|
Drugs to treat Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Contraindications; Ergoloid Mesylates; Humans; Isoxsuprine; Memantine; Noot | 2013 |
Drugs to treat Alzheimer's disease.
Topics: Alzheimer Disease; Central Nervous System Agents; Cholinesterase Inhibitors; Contraindications; Ergo | 2009 |